-
621
VCP downstream metabolite glycerol-3-phosphate (G3P) inhibits CD8+T cells function in the HCC microenvironment
Published 2025-01-01“…Here, we identified valosin-containing protein (VCP) as a key regulator of CD8+T cells suppression in hepatocellular carcinoma (HCC). Our findings reveal that VCP suppresses the activation, expansion, and cytotoxic capacity of CD8+T cells both in vitro and in vivo, significantly contributing to the immunosuppressive nature of the TME. …”
Get full text
Article -
622
Real-life study on the effectiveness and safety of sofosbuvir/velpatasvir-based antiviral agents for hepatitis C eradication in Chinese patients
Published 2024-12-01“…Patients included adults with with CHC and any genotype (GT), with or without cirrhosis, hepatocellular carcinoma (HCC), HCV/HBV, HCV/HIV, or HCV/HBV/HIV coinfection. …”
Get full text
Article -
623
A patient-derived HCC spheroid system to model the tumor microenvironment and treatment response
Published 2025-02-01“…Background & Aims: Hepatocellular carcinoma (HCC) is the third-leading and fastest rising cause of cancer-related death worldwide. …”
Get full text
Article -
624
Protein tyrosine phosphatase delta is a STAT3-phosphatase and suppressor of metabolic liver disease
Published 2025-01-01“…Objective Impaired hepatic expression of protein tyrosine phosphatase delta (PTPRD) is associated with increased STAT3 transcriptional activity and reduced survival from hepatocellular carcinoma in patients with chronic hepatitis C virus infection. …”
Get full text
Article -
625
Synthesis, Superoxide Dismutase Mimetic and Anticancer Activities of Metal Complexes of 2,2-Dimethylpentanedioic Acid(2<small.letters>dmepda</small.letters>H<mml:math> <mml:mrow>...
Published 2006-01-01“…The dimethyl sulphoxide(DMSO) soluble complexes (<bold>1</bold>)–(<bold>4</bold>) and (<bold>6</bold>) were assessed for their cancer chemotherapeutic potential towards hepatocellular carcinoma and kidney adenocarcinoma cell lines. …”
Get full text
Article -
626
Current Treatment Approaches to HCC with a Special Consideration to Transplantation
Published 2016-01-01“…Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. …”
Get full text
Article -
627
The Features of Extrahepatic Collateral Arteries Related to Hepatic Artery Occlusion and Benefits in the Transarterial Management of Liver Tumors
Published 2013-01-01“…Eleven patients (7 hepatocellular carcinomas, 3 liver metastases, and 1 with hemangioma) with HAO confirmed with digital subtraction angiography (DSA) were admitted to our hospital. …”
Get full text
Article -
628
Evaluation of the immunological functions of placental alkaline phosphatase in vivo using ALPP transgenic mice
Published 2025-02-01“…Placental alkaline phosphatase (ALPP) is one of tissue-specific ALP isozymes expressed mostly during pregnancy, however it was found to be differentially upregulated in certain hepatocellular carcinomas by us recently. In addition, ALPP has been identified as a reliable biomarker of diverse germ cell tumors. …”
Get full text
Article -
629
Inhibition of mutagenic activation of orthoaminoazotoluene increases its carcinogenicity for mouse liver
Published 2016-12-01“…The results of our comparative study with ortho-aminoazotoluene and 3.4-benzopyrene are in contradiction with the genotoxic theory of carcinogenesis: both are similarly activated by mouse liver enzymes, but induce tumors in different tissues: the former, hepatocellular carcinomas and the latter, splenic lymphoma. …”
Get full text
Article